Skip to main content
OpenTrials

Clinical trial condition

HIV Infection

Explore clinical trials studying HIV Infection. Study availability and eligibility vary by location and protocol.

540 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

HIV Infection trial results

Active, Not Recruiting

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT04929028

Conditions
AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma, +34 more
Locations
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • George Washington University Medical Center Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Illinois Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

NCT02797470

Conditions
Blood-Borne Infections, Burkitt Lymphoma, Communicable Diseases, +41 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)

NCT05766501

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • University of Alabama at Birmingham-UAB 1917 Research Clinic ( Site 3104) Birmingham, Alabama, United States
  • Pueblo Family Physicians ( Site 3102) Phoenix, Arizona, United States
  • Pacific Oaks Medical Group ( Site 3123) Beverly Hills, California, United States
  • Kaiser Permanente ( Site 3124) Los Angeles, California, United States
View all 95 locations
View Trial Details
Active, Not Recruiting

Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico

NCT05074264

Conditions
AIDS-Related Anal Carcinoma, AIDS-Related Cervical Carcinoma, Blood-Borne Infections, +16 more
Locations
  • Condesa Specialized Clinic Mexico City, Mexico
  • Condesa Iztapalapa Specialized Clinic Mexico City, Mexico
  • Instituto Nacional de Cancerologia (INCan) Mexico City, Mexico
  • University of Puerto Rico Comprehensive Cancer Center San Juan, PR, Puerto Rico
View Trial Details

Related conditions